A Wish Come True for Logan

For children facing neuroblastoma, life can often be defined by hospital visits, treatments, and uncertainty. But every so often, a moment of pure joy cuts through – and for Logan, that moment came in an unforgettable way. Logan was diagnosed with neuroblastoma in 2021, when he was just 11 months old. While his initial treatment […]

2026 Grant Round: Focus on Immunotherapy

Neuroblastoma Australia is pleased to announce that our 2026 Grant Round is underway.  In 2026, our funding will focus specifically on Immunotherapy, a rapidly evolving area of research that holds enormous promise for improving outcomes for children diagnosed with neuroblastoma. Advances in immunotherapy are creating new opportunities for more targeted, less toxic treatments, offering hope […]

Prof. Gudrun Schleiermacher Joins NBA Advisory Board

Introducing Our New Scientific Advisory Board Member We are exceptionally proud of our world-class Scientific Advisory Board, which plays a vital role in assessing funding for proposed research projects. We are thrilled to welcome Professor Gudrun Schleiermacher as the newest member of the Board.  Professor Gudrun Schleiermacher is a leading paediatric oncologist and researcher at Institut […]